AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

Sep 20, 2025 · AUSTEDO XR (deutetrabenazine) extended-release tablets and AUSTEDO (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.

Deutetrabenazine (AUSTEDO) and Deutetrabenazine extended-release tablets (AUSTEDO XR) Criteria for Use VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN …

Nov 7, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to …

Sep 22, 2025 · Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction Monday, September 22, 2025 Teva Pharmaceuticals, …

If you have Huntington's disease, deutetrabenazine can sometimes increase the risk of depression and suicidal thoughts/attempts. People with Huntington's disease are already more likely to have …

Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

If you are taking deutetrabenazine for Huntington’s disease, you may start at an even lower dose. Patients starting on the extended-release tablets begin at 12 mg once a day and the dose may be …